Author

B. J. Venters

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:ChIP-seq· 2 Approach:experimental assay· 2 Research Focus:benchmarking· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:chromatin & epigenetic regulation· 1 Assay:CUT&Tag· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

A. Hickman· 1 shared A. P. Shaw· 1 shared A. Shilatifard· 1 shared B. F. Pugh· 1 shared C. L. Windham· 1 shared C. Lu· 1 shared D. James· 1 shared D. Maryanski· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Hickman

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer-associated DNA Hypermethylation of Polycomb Targets Requires DNMT3A Dual Recognition of Histone H2AK119 Ubiquitination and the Nucleosome Acidic Patch

K. H. Gretarsson, S. Abini-Agbomson, S. Gloor, D. N. Weinberg, J. L. McCuiston, V. U. N. S. Kumary, A. Hickman, V. Sahu, R. Lee, X. Xu, N. Lipieta, S. Flashner, O. A. Adeleke, I. K. Popova, H. Taylor, , C. Lu

The paper identifies a critical binding interface in DNMT3A1 that facilitates DNA hypermethylation at Polycomb target genes by recognizing H2AK119Ub and the nucleosome acidic patch.

bioRxiv · Mar 18, 2024Cancer Biology

A ChIP-exo screen of 887 PCRP transcription factor antibodies in human cells

W. K. Lai, L. Mariani, G. Rothschild, E. R. Smith, B. J. Venters, T. R. Blanda, P. K. Kuntala, K. Bocklund, J. Mairose, S. N. Dweikat, K. Mistretta, M. J. Rossi, D. James, J. T. Anderson, S. K. Phanor, , B. F. Pugh

The paper evaluates 887 PCRP antibodies against human transcription factors using ChIP-exo and other assays, identifying 5% as strong candidates and 34% as warranting further testing.

bioRxiv · Jun 8, 2020Biochemistry